Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$611.76 USD

611.76
175,117

-12.45 (-2.00%)

Updated Sep 11, 2024 11:11 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

AMN Healthcare (AMN) Hits 52-Week High: What's Behind It?

Investors are optimistic about AMN Healthcare's (AMN) broad array of services.

IDEXX's (IDXX) Organic Growth Robust, LPD Revenues Decline

IDEXX's (IDXX) global Reference Lab businesses continue to be robust driven by high same-store volume growth with strong gains across testing categories.

Alcon (ALC) Vision Care Sales Grow Despite Supply Disruption

Alcon's (ALC) new contact lenses are gaining market share and the Systane brand family has been posting strong double-digit growth in all regions.

Abbott (ABT) Scales to a 52-Week High: What's Driving It?

Strength in Diabetes Care and Diagnostics businesses is driving Abbott's (ABT) top line.

AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It?

Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.

OPKO's (OPK) RAYALDEE Favored by Trial Data for COVID Patients

Latest trial results indicate that using OPKO's (OPK) RAYALDEE may improve vitamin D status for faster relief from respiratory symptoms for COVID-19 patients.

LabCorp (LH) to Expand Oncology Portfolio With Latest Buyout

LabCorp's (LH) acquisition of PGDx will position the company at the forefront of driving better patient outcomes in oncology.

Here's Why You Should Hold on to Integra (IART) Stock for Now

Investors are optimistic about Integra's (IART) strong third-quarter performance and ongoing recovery across its business.

Urmimala Biswas headshot

Forget Zimmer Biomet (ZBH), Buy These 3 Medical Devices Stocks

With orthopedic stocks like Zimmer Biomet (ZBH) are grappling with several issues, it is wise to invest in medical device stocks like TMO, NEOG and CERN instead for 2022.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and dental business.

BD (BDX) Partners With Retailers for At-Home COVID-19 Test

BD (BDX) collaborates with retail partners and distributors to make the BD Veritor At-Home COVID-19 Test widely accessible.

Quidel (QDEL) Inks Buyout Deal to Solidify Its Diagnostics Arm

Quidel's (QDEL) latest buyout is expected to expand its point-of-care diagnostics portfolio as well as geographic footprint.

Thermo Fisher (TMO) Releases New Update for Omicron Detection

Thermo Fisher's (TMO) TaqMan SARS-CoV-2 Mutation Panel currently offers direct identification of the novel variant of concern.

Hologic (HOLX) to Meet High Testing Demand With Panther Trax

Hologic's (HOLX) Panther Trax scalable solutions will meet the needs of today's laboratories, enabling them to expand operational capacity and testing volumes.

Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $650.70, moving -0.15% from the previous trading session.

Medtronic (MDT) to Gain From Expanded Medicare Coverage for CGM

CMS' expanded Medicare coverage includes continuous glucose monitors that can be integrated with Medtronic's (MDT) insulin pumps.

BD's (BDX) Latest Buyout to Enhance its Digital Capabilities

BD's (BDX) acquisition of Scanwell is expected to significantly transform its at-home solutions both at present and in the future.

Here's Why You Should Retain Merit Medical (MMSI) Stock For Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.

Exact Sciences (EXAS) Rides on Cologuard Sales Amid COVID Fear

Exact Sciences (EXAS) is planning several key milestones to bring six innovative cancer diagnostics from its pipeline to patients in need.

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

Investors are optimistic about Henry Schein's (HSIC) better-than-expected third-quarter results and robust performances by its operating businesses.

Here's Why You Should Retain Quest Diagnostics (DGX) Stock Now

Investors are optimistic about Quest Diagnostics' (DGX) strong third-quarter performance and raised guidance.

Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know

In the latest trading session, Thermo Fisher Scientific (TMO) closed at $651.70, marking a +0.99% move from the previous day.

Here's Why You Should Retain Masimo (MASI) Stock For Now

Investors continue to be optimistic about Masimo (MASI) owing to its focus on patient-monitoring.

Zimmer Biomet (ZBH) Americas Business Slows Down Amid Pandemic

Zimmer Biomet (ZBH) continues to face COVID-induced challenges and market pressure.